🏛️ Verified NIH Record • Updated 2025-05-08
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions (NCT04540900)
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic Sponsor: Krystal Biotech, Inc.
🩺 Plain-English Summary (8th-Grade Level)
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
Who can join: Review the eligibility criteria below.
Location: Aesthetx — Campbell, California
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Aesthetx — Campbell, California
- Steve Yoelin, MD Medical Associates, Inc. — Newport Beach, California
- Mission Dermatology — Rancho Santa Margarita, California
- Skin and Cancer Associates, LLP. D/B/A Center for Clinical and Cosmetic Research — Aventura, Florida
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Skin Roughness clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.